Huntington National Bank »

Madrigal Pharmaceuticals shares owned by Huntington National Bank

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 53 231.38
2023-09-30 $7.7k 53 146.04

More positions owned by Huntington National Bank

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Jp Morgan Chase & Co Common Stock (JPM)
Nvidia Corp Common Stock (NVDA)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IJR)
Alphabet Common Stock (GOOGL)
Ishares Exchange Traded (Principal) (IJH)
Ishares Exchange Traded (Principal) (IVW)
Amazon.com Common Stock (AMZN)
Eli Lilly & Co Common Stock (LLY)
Ishares Exchange Traded (Principal) (IVE)
Visa Common Stock (V)
Exxon Mobil Corp Common Stock (XOM)
Spdr S&p 500 Etf Trust Exchange Traded (Principal) (SPY)

View all positions for Huntington National Bank

Top funds holding Madrigal Pharmaceuticals

Henderson Group
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
Paulson & Co
T. Rowe Price Associates
Alliancebernstein
Artisan Partners Limited Partnership
Jane Street
AlpInvest Partners B.V.
RA Capital Management
Perceptive Advisors
Norges Bank Investment Management
Bank of America Corporation
Citadel Advisors

View all funds holding Madrigal Pharmaceuticals